Novo Nordisk loses another patent behind Ozempic and Wegovy drugs
The EPO has reversed its preliminary opinion in the case of another Novo Nordisk patent and revoked it. Generic drug manufacturers could enter the market several years earlier,…
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 9 03:00 ETSource: JUVE Patent
From the source
Read at juve-patent.comNovo Nordisk loses another patent behind Ozempic and Wegovy drugs
The EPO has reversed its preliminary opinion in the case of another Novo Nordisk patent and revoked it. Generic drug manufacturers could enter the market several years earlier, possibly as early as 2031.
